Monogram Orthopaedics, Inc. (MGRM)
| Market Cap | 65.24M |
| Revenue (ttm) | 364,999 |
| Net Income (ttm) | -13.39M |
| Shares Out | 31.67M |
| EPS (ttm) | -0.50 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 81,834 |
| Open | 2.050 |
| Previous Close | 2.080 |
| Day's Range | 2.000 - 2.190 |
| 52-Week Range | 1.530 - 6.550 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 14, 2024 |
About MGRM
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monog... [Read more]
Financial Performance
Financial StatementsNews
Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
Management to Showcase Product Demonstration of mBôs Precision Robotic Surgical System and mVision Technologies AUSTIN, TX / ACCESSWIRE / June 3, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Mono...
Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies
New Name Reflects Continued Evolution as an AI-Driven Robotics Company with a Strong IP Position AUSTIN, TX / ACCESSWIRE / May 15, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "C...
Monogram Orthopaedics Reports First Quarter 2024 Financial Results
Verification and Validation Testing Expected to be Largely Complete in Q2 2024; 510(k) Submission with FDA Accelerated for Second Half of 2024 Engaged Contract Research Organization to Oversee mBôs Ro...
Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.
CRO Expands Clinical Capabilities, Accelerating Product Pipeline Development and Commercialization Opportunities AUSTIN, TX / ACCESSWIRE / May 13, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Mon...
Monogram Provides Regulatory Update Following Meeting with FDA
510(k) Submission with FDA Accelerated for Early Second Half of 2024 AUSTIN, TX / ACCESSWIRE / May 1, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven roboti...
Monogram Accepted to NVIDIA Inception Program
Collaboration to Provide Monogram with Technical Resources to Drive Development and Commercialization of mBôs System AUSTIN, TX / ACCESSWIRE / April 11, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM)...
Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time
AUSTIN, TX / ACCESSWIRE / March 20, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical ...
Monogram Orthopaedics Reports Full Year 2023 Financial Results
510(k) Submission with FDA On Track for Second Half of 2024 Shipped mBôs Surgical Robot System to First International Customer Introduced mVision Technologies, a Novel Approach to Registration and Tra...
Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting
Event features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeons AUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Compa...
Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024
AUSTIN, TX / ACCESSWIRE / January 24, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgica...
Monogram Orthopaedics to Reschedule Robotic Product Demo Live Stream
AUSTIN, TX / ACCESSWIRE / December 14, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgic...
Monogram Orthopaedics to Host Robotic Product Demo Live Stream on Thursday, December 14, 2023 at 11:00 a.m. Eastern Time
- Demo will feature Monogram's mBôs commercial robot with teaser - AUSTIN, TX / ACCESSWIRE / November 30, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical techn...
Monogram Orthopaedics Delivers First Surgical Robot
- First Sale to Major Global Distributor Represents Key Revenue Milestone and Paves the Way for Broader Commercialization - AUSTIN, TX / ACCESSWIRE / November 28, 2023 / Monogram Orthopaedics Inc. (NA...
Monogram Orthopaedics Files Updated Presentation on Form 8-K
- Presentation Highlights MGRM's Competitive Differentiation and Multi-Stage Growth Strategy - AUSTIN, TX / ACCESSWIRE / October 20, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the ...
Monogram Orthopaedics' Next Generation Surgical Robotic System Enters Verification Phase
Completion of the Development Phase Represents a Key Milestone Toward Product Commercialization AUSTIN, TX / ACCESSWIRE / August 14, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the ...
Monogram Orthopaedics Secures First Conditional Purchase Order to Initiate Pilot Program with Global Distributor
Moves from R&D to Commercialization AUSTIN, TX / ACCESSWIRE / July 18, 2023 / Monogram Orthopaedics Inc., (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstru...
Monogram Orthopaedics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
AUSTIN, TX / ACCESSWIRE / May 23, 2023 / Monogram Orthopaedics Inc., (NASDAQ:MGRM) ("Monogram" or the "Company") a medical technology company focused on reconstructive joint procedures and orthopedic ...
Monogram Orthopaedics shares rally, Farfetch stock gains and other stocks on the move
Monogram Orthopaedics Inc. MGRM, +62.07% shares surged 278% in premarket trading. The medical technology group began trading on the Nasdaq on Thursday, with the stock ending the first day of trading a...
Monogram Orthopaedics Shares Begin Trading Publicly on NASDAQ
Medical Technology Company Ushering in the Future of Joint Reconstruction Will Trade Under Ticker Symbol "MGRM" AUSTIN, TX / ACCESSWIRE / May 18, 2023 / Monogram Orthopedics (NASDAQ:MGRM), a leader in...
Monogram Orthopaedics Announces Closing of Public Offering of $17,216,147
Shares to Begin Trading on NASDAQ on May 18, 2023 Under the Ticker Symbol "MGRM" AUSTIN, TX / ACCESSWIRE / May 17, 2023 / Monogram Orthopaedics Inc., a leader in developing patient-optimized, 3D-print...